Abstract
Monensin resistance in a field strain of Eimeria tenella (FS139) was successfully amplified by an in vitro method. Sporozoites of parent FS139, designated as FS139(0), were treated with monensin at 5 μg ml −1 before inoculation into chickens. Oocysts developing from these drug-treated sporozoites were designated FS139(5). Sporozoites of FS139(5) were then treated with a higher level of monensin (25 μg ml −1), which produced another line called FS139(25). Sporozoites of FS139(25) received a monensin treatment of 100 μg ml −1 which yielded line FS139(100). After one passage in chickens, sporozoites of FS139(0), FS139(25) and FS139(100) were treated with either 0, 1, 25, or 100 μg ml −1 of monensin and inoculated into chicken primary kidney cell cultures to observe sporozoite invasion rates and development of first generation schizonts. Data on invasion rates and development of schizonts showed that FS139(100) was the most drug-resistant line while FS139(25) was the second most resistant line compared with the parent line FS139(0). These in vitro treatment techniques could be used to develop resistant coccidia for laboratory study of the physiological mechanisms of resistance.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.